Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
J Med Chem ; 66(17): 11893-11904, 2023 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-37584282

RESUMEN

Candida glabrata has emerged as an important opportunistic pathogen of invasive candidiasis due to increasing drug resistance. Targeting Pdr1-KIX interactions with small molecules represents a potential strategy for treating drug-resistant candidiasis. However, effective Pdr1-KIX inhibitors are rather limited, hindering the validation of target druggability. Here, new Pdr1-KIX inhibitors were designed and assayed. Particularly, compound B8 possessed a new chemical scaffold and exhibited potent KIX binding affinity, leading to enhanced synergistic efficacy with fluconazole to treat resistant C. glabrata infection (FICI = 0.28). Compound B8 acted by inhibiting the efflux pump and down-regulating resistance-associated genes through blocking the Pdr1-KIX interaction. Compound B8 exhibited excellent in vitro and in vivo antifungal potency in combination with fluconazole against azole-resistant C. glabrata. It also had direct antifungal effect to treat C. glabrata infection, suggesting new mechanisms of action independent of Pdr1-KIX inhibition. Therefore, compound B8 represents a promising lead compound for antifungal drug development.


Asunto(s)
Candidiasis , Pirazolonas , Antifúngicos/farmacología , Antifúngicos/uso terapéutico , Antifúngicos/metabolismo , Azoles/farmacología , Azoles/uso terapéutico , Azoles/metabolismo , Candida glabrata/genética , Candida glabrata/metabolismo , Candidiasis/tratamiento farmacológico , Candidiasis/microbiología , Farmacorresistencia Fúngica , Fluconazol/farmacología , Fluconazol/uso terapéutico , Proteínas Fúngicas/metabolismo , Pirazolonas/farmacología , Factores de Transcripción/metabolismo , Tioamidas
2.
PLoS One ; 17(3): e0265777, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35303047

RESUMEN

Invasive fungal infections, which kill more than 1.6 million patients each year worldwide, are difficult to treat due to the limited number of antifungal drugs (azoles, echinocandins, and polyenes) and the emergence of antifungal resistance. The transcription factor Crz1, a key regulator of cellular stress responses and virulence, is an attractive therapeutic target because this protein is absent in human cells. Here, we used a CRISPR-Cas9 approach to generate isogenic crz1Δ strains in two clinical isolates of caspofungin-resistant C. glabrata to analyze the role of this transcription factor in susceptibility to echinocandins, stress tolerance, biofilm formation, and pathogenicity in both non-vertebrate (Galleria mellonella) and vertebrate (mice) models of candidiasis. In these clinical isolates, CRZ1 disruption restores the susceptibility to echinocandins in both in vitro and in vivo models, and affects their oxidative stress response, biofilm formation, cell size, and pathogenicity. These results strongly suggest that Crz1 inhibitors may play an important role in the development of novel therapeutic agents against fungal infections considering the emergence of antifungal resistance and the low number of available antifungal drugs.


Asunto(s)
Candida glabrata , Equinocandinas , Animales , Antifúngicos/farmacología , Antifúngicos/uso terapéutico , Sistemas CRISPR-Cas/genética , Calcineurina/metabolismo , Candida glabrata/genética , Candida glabrata/metabolismo , Farmacorresistencia Fúngica/genética , Equinocandinas/farmacología , Equinocandinas/uso terapéutico , Humanos , Ratones , Pruebas de Sensibilidad Microbiana , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Zinc/metabolismo , Dedos de Zinc
3.
Artículo en Inglés | MEDLINE | ID: mdl-31345844

RESUMEN

We report the case of a 61-year-old female with Crohn's disease dependent on total parenteral nutrition who developed a central venous catheter bloodstream infection and septic arthritis, complicated further by osteomyelitis and persistent Candida glabrata fungemia. Fluconazole treatment led to persistent infection, and micafungin therapy failed with development of FKS-associated resistance. Infection responded after initiation of amphotericin B plus voriconazole. Echinocandin resistance is increasingly recognized, suggesting a role for alternative antifungal therapies.


Asunto(s)
Anfotericina B/uso terapéutico , Artritis Infecciosa/tratamiento farmacológico , Candida glabrata/efectos de los fármacos , Farmacorresistencia Fúngica/efectos de los fármacos , Equinocandinas/uso terapéutico , Osteomielitis/tratamiento farmacológico , Voriconazol/uso terapéutico , Antifúngicos/uso terapéutico , Artritis Infecciosa/microbiología , Candida glabrata/metabolismo , Candidiasis/tratamiento farmacológico , Candidiasis/microbiología , Proteínas Fúngicas/metabolismo , Humanos , Persona de Mediana Edad , Osteomielitis/microbiología , Terapia Recuperativa/métodos
4.
FEMS Yeast Res ; 16(5)2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-27370212

RESUMEN

Vacuolar H(+)-ATPase (V-ATPase) is responsible for the acidification of eukaryotic intracellular compartments and plays an important role in oxidative stress response (OSR), but its molecular bases are largely unknown. Here, we investigated how V-ATPase is involved in the OSR by using a strain lacking VPH2, which encodes an assembly factor of V-ATPase, in the pathogenic fungus Candida glabrata The loss of Vph2 resulted in increased H2O2 sensitivity and intracellular reactive oxygen species (ROS) level independently of mitochondrial functions. The Δvph2 mutant also displayed growth defects under alkaline conditions accompanied by the accumulation of intracellular ROS and these phenotypes were recovered in the presence of the ROS scavenger N-acetyl-l-cysteine. Both expression and activity levels of mitochondrial manganese superoxide dismutase (Sod2) and catalase (Cta1) were decreased in the Δvph2 mutant. Phenotypic analyses of strains lacking and overexpressing these genes revealed that Sod2 and Cta1 play a predominant role in endogenous and exogenous OSR, respectively. Furthermore, supplementation of copper and iron restored the expression of SOD2 specifically in the Δvph2 mutant, suggesting that the homeostasis of intracellular cupper and iron levels maintained by V-ATPase was important for the Sod2-mediated OSR. This report demonstrates novel roles of V-ATPase in the OSR in C. glabrata.


Asunto(s)
Candida glabrata/enzimología , Candida glabrata/fisiología , Cobre/metabolismo , Estrés Oxidativo , ATPasas de Translocación de Protón/metabolismo , Vacuolas/enzimología , Vacuolas/metabolismo , Álcalis/toxicidad , Candida glabrata/genética , Candida glabrata/metabolismo , Catalasa/metabolismo , Citosol/química , Eliminación de Gen , Peróxido de Hidrógeno/toxicidad , Chaperonas Moleculares/genética , Especies Reactivas de Oxígeno/análisis , Superóxido Dismutasa/metabolismo
5.
Antimicrob Agents Chemother ; 60(1): 662-5, 2016 01.
Artículo en Inglés | MEDLINE | ID: mdl-26525799

RESUMEN

Treatment of Candida glabrata cystitis remains a therapeutic challenge, and an antifungal combination using flucytosine is one option. We describe two patients with refractory C. glabrata cystitis who failed flucytosine combined with caspofungin with early-acquired high-level resistance to flucytosine due to nonsense mutations in the FUR1 gene. Rapidly acquired flucytosine resistance with microbiological failure should discourage combination of caspofungin and flucytosine during urinary candidiasis.


Asunto(s)
Antifúngicos/administración & dosificación , Candida glabrata/efectos de los fármacos , Candidiasis/tratamiento farmacológico , Cistitis/tratamiento farmacológico , Farmacorresistencia Fúngica/efectos de los fármacos , Equinocandinas/administración & dosificación , Flucitosina/administración & dosificación , Lipopéptidos/administración & dosificación , Anciano , Secuencia de Bases , Candida glabrata/genética , Candida glabrata/aislamiento & purificación , Candida glabrata/metabolismo , Candidiasis/microbiología , Candidiasis/patología , Caspofungina , Codón sin Sentido , Cistitis/microbiología , Cistitis/patología , Farmacorresistencia Fúngica/genética , Quimioterapia Combinada , Femenino , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Expresión Génica , Humanos , Masculino , Datos de Secuencia Molecular , Proteínas de Transporte de Nucleobases/genética , Proteínas de Transporte de Nucleobases/metabolismo , Insuficiencia del Tratamiento , Vejiga Urinaria/microbiología , Vejiga Urinaria/patología
6.
FEMS Yeast Res ; 13(4): 411-21, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23496820

RESUMEN

The pathogenic fungus Candida glabrata is relatively resistant to azole antifungals, which target lanosterol 14α-demethylase (Erg11p) in the ergosterol biosynthesis pathway. Our study revealed that C. glabrata exhibits increased azole susceptibility under low-iron conditions. To investigate the molecular basis of this phenomenon, we generated a strain lacking the heme (iron protoporphyrin IX)-binding protein Dap1 in C. glabrata. The Δdap1 mutant displayed growth defects under iron-limited conditions, decreased azole tolerance, decreased production of ergosterol, and increased accumulation of 14α-methylated sterols lanosterol and squalene. All the Δdap1 phenotypes were complemented by wild-type DAP1, but not by DAP1(D91G) , in which a heme-binding site is mutated. Furthermore, azole tolerance of the Δdap1 mutant was rescued by exogenous ergosterol but not by iron supplementation alone. These results suggest that heme binding by Dap1 is crucial for Erg11 activity and ergosterol biosynthesis, thereby being required for azole tolerance. A Dap1-GFP fusion protein predominantly localized to vacuolar membranes and endosomes, and the Δdap1 cells exhibited aberrant vacuole morphologies, suggesting that Dap1 is also involved in the regulation of vacuole structures that could be important for iron storage. Our study demonstrates that Dap1 mediates a functional link between iron homeostasis and azole resistance in C. glabrata.


Asunto(s)
Antifúngicos/farmacología , Azoles/farmacología , Candida glabrata/efectos de los fármacos , Proteínas Portadoras/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Farmacorresistencia Fúngica , Hemoproteínas/metabolismo , Hierro/metabolismo , Candida glabrata/genética , Candida glabrata/crecimiento & desarrollo , Candida glabrata/metabolismo , Proteínas Portadoras/genética , Eliminación de Gen , Prueba de Complementación Genética , Proteínas de Unión al Hemo , Hemoproteínas/genética , Homeostasis , Lanosterol/metabolismo , Escualeno/metabolismo
7.
Antimicrob Agents Chemother ; 56(8): 4223-32, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22615281

RESUMEN

We identified a clinical isolate of Candida glabrata (CG156) exhibiting flocculent growth and cross-resistance to fluconazole (FLC), voriconazole (VRC), and amphotericin B (AMB), with MICs of >256, >256, and 32 µg ml(-1), respectively. Sterol analysis using gas chromatography-mass spectrometry (GC-MS) revealed that CG156 was a sterol 14α-demethylase (Erg11p) mutant, wherein 14α-methylated intermediates (lanosterol was >80% of the total) were the only detectable sterols. ERG11 sequencing indicated that CG156 harbored a single-amino-acid substitution (G315D) which nullified the function of native Erg11p. In heterologous expression studies using a doxycycline-regulatable Saccharomyces cerevisiae erg11 strain, wild-type C. glabrata Erg11p fully complemented the function of S. cerevisiae sterol 14α-demethylase, restoring growth and ergosterol synthesis in recombinant yeast; mutated CG156 Erg11p did not. CG156 was culturable using sterol-free, glucose-containing yeast minimal medium ((glc)YM). However, when grown on sterol-supplemented (glc)YM (with ergosta 7,22-dienol, ergosterol, cholestanol, cholesterol, Δ(7)-cholestenol, or desmosterol), CG156 cultures exhibited shorter lag phases, reached higher cell densities, and showed alterations in cellular sterol composition. Unlike comparator isolates (harboring wild-type ERG11) that became less sensitive to FLC and VRC when cultured on sterol-supplemented (glc)YM, facultative sterol uptake by CG156 did not affect its azole-resistant phenotype. Conversely, CG156 grown using (glc)YM with ergosterol (or with ergosta 7,22-dienol) showed increased sensitivity to AMB; CG156 grown using (glc)YM with cholesterol (or with cholestanol) became more resistant (MICs of 2 and >64 µg AMB ml(-1), respectively). Our results provide insights into the consequences of sterol uptake and metabolism on growth and antifungal resistance in C. glabrata.


Asunto(s)
Anfotericina B/farmacología , Antifúngicos/farmacología , Azoles/farmacología , Candida glabrata/metabolismo , Farmacorresistencia Fúngica Múltiple/genética , Mutación Missense , Esterol 14-Desmetilasa/genética , Secuencia de Bases , Transporte Biológico , Candida glabrata/efectos de los fármacos , Candida glabrata/genética , Candida glabrata/aislamiento & purificación , Ergosterol/metabolismo , Fluconazol/farmacología , Proteínas Fúngicas/genética , Humanos , Pruebas de Sensibilidad Microbiana , Pirimidinas/farmacología , Saccharomyces cerevisiae/metabolismo , Análisis de Secuencia de ADN , Esteroles/metabolismo , Triazoles/farmacología , Voriconazol
8.
Eukaryot Cell ; 10(11): 1376-83, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21926328

RESUMEN

Recently, mitochondria have been identified as important contributors to the virulence and drug tolerance of human fungal pathogens. In different scenarios, either hypo- or hypervirulence can result from changes in mitochondrial function. Similarly, specific mitochondrial mutations lead to either sensitivity or resistance to antifungal drugs. Here, we provide a synthesis of this emerging field, proposing that mitochondrial function in membrane lipid homeostasis is the common denominator underlying the observed effects of mitochondria in drug tolerance (both sensitivity and resistance). We discuss how the contrasting effects of mitochondrial dysfunction on fungal drug tolerance and virulence could be explained and the potential for targeting mitochondrial factors for future antifungal drug development.


Asunto(s)
Antifúngicos/farmacología , Farmacorresistencia Fúngica , Hongos/efectos de los fármacos , Hongos/patogenicidad , Mitocondrias/fisiología , Membranas Mitocondriales/metabolismo , Micosis/tratamiento farmacológico , Antifúngicos/metabolismo , Azoles/farmacología , Candida albicans/efectos de los fármacos , Candida albicans/metabolismo , Candida albicans/patogenicidad , Candida glabrata/efectos de los fármacos , Candida glabrata/metabolismo , Candida glabrata/patogenicidad , Cryptococcus neoformans/efectos de los fármacos , Cryptococcus neoformans/metabolismo , Cryptococcus neoformans/patogenicidad , Descubrimiento de Drogas , Farmacorresistencia Fúngica/genética , Hongos/genética , Hongos/metabolismo , Humanos , Lípidos de la Membrana/metabolismo , Pruebas de Sensibilidad Microbiana , Mitocondrias/efectos de los fármacos , Mitocondrias/genética , Micosis/microbiología , Polienos/farmacología , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/patogenicidad
9.
Annu Rev Nutr ; 28: 115-30, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18429699

RESUMEN

Although baseline requirements for nicotinamide adenine dinucleotide (NAD+) synthesis can be met either with dietary tryptophan or with less than 20 mg of daily niacin, which consists of nicotinic acid and/or nicotinamide, there is growing evidence that substantially greater rates of NAD+ synthesis may be beneficial to protect against neurological degeneration, Candida glabrata infection, and possibly to enhance reverse cholesterol transport. The distinct and tissue-specific biosynthetic and/or ligand activities of tryptophan, nicotinic acid, nicotinamide, and the newly identified NAD+ precursor, nicotinamide riboside, reviewed herein, are responsible for vitamin-specific effects and side effects. Because current data suggest that nicotinamide riboside may be the only vitamin precursor that supports neuronal NAD+ synthesis, we present prospects for human nicotinamide riboside supplementation and propose areas for future research.


Asunto(s)
Dislipidemias/tratamiento farmacológico , NAD/metabolismo , Niacina/metabolismo , Niacinamida/análogos & derivados , Niacinamida/metabolismo , Animales , Restricción Calórica , Candida glabrata/metabolismo , Suplementos Dietéticos , Dislipidemias/sangre , Humanos , NAD/biosíntesis , Necesidades Nutricionales , Compuestos de Piridinio
10.
Photochem Photobiol ; 84(5): 1141-8, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18248505

RESUMEN

Mucosal infections caused by the pathogenic fungus Candida are a significant infectious disease problem and are often difficult to eradicate because of the high frequency of resistance to conventional antifungal agents. Photodynamic treatment (PDT) offers an attractive therapeutic alternative. Previous studies demonstrated that filamentous forms and biofilms of Candida albicans were sensitive to PDT using Photofrin as a photosensitizer. However, early stationary phase yeast forms of C. albicans and Candida glabrata were not adversely affected by treatment. We report that the cationic porphyrin photosensitizer meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate (TMP-1363) is effective in PDT against yeast forms of C. albicans and C. glabrata. Respiratory-deficient (RD) strains of C. albicans and C. glabrata display a pleiotropic resistance pattern, including resistance to members of the azole family of antifungals, the salivary antimicrobial peptides histatins and other types of toxic stresses. In contrast to this pattern, RD mutants of both C. albicans and C. glabrata were significantly more sensitive to PDT compared to parental strains. These data suggest that intact mitochondrial function may provide a basal level of anti-oxidant defense against PDT-induced phototoxicity in Candida, and reveals pathways of resistance to oxidative stress that can potentially be targeted to increase the efficacy of PDT against this pathogenic fungus.


Asunto(s)
Candida albicans/efectos de los fármacos , Candida albicans/metabolismo , Candida glabrata/efectos de los fármacos , Candida glabrata/metabolismo , Consumo de Oxígeno , Fármacos Fotosensibilizantes/farmacología , Porfirinas/farmacología , Antifúngicos/farmacología , Biopelículas/efectos de los fármacos , Candida albicans/genética , Candida albicans/patogenicidad , Candida glabrata/genética , Candida glabrata/patogenicidad , Éter de Dihematoporfirina/farmacología , Hifa/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Mutación , Estrés Oxidativo , Fotoquimioterapia
11.
J Biotechnol ; 126(2): 173-85, 2006 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-16713000

RESUMEN

This study aimed at increasing the pyruvate productivity from a multi-vitamin auxotrophic yeast Torulopsis glabrata, by increasing the availability of NAD+. We examined two strategies for increasing availability of NAD+. To supplement nicotinic acid (NA), the precursor of NAD+; and to increase the activity of alcohol dehydrogenase integrating with addition acetaldehyde as exterior electron acceptor. The addition of 8 mg l(-1) NA to the fermentation medium resulted in a significant increase in the glucose consumption rate (48.4%) and the pyruvate concentration (29%). An ethanol-utilizing mutant WSH-13 was screened and selected after nitrosoguanidine mutagenesis of the parent strain T. glabrata CCTCC M202019. Compared with the parent strain, the alcohol dehydrogenase activity of the mutant WSH-13 increased about 110% and the mutant could utilize ethanol as the sole carbon source for growth (1.8 g l(-1) dry cell weight). When growing with glucose, the addition of 4 mg l(-1) acetaldehyde to the mutant WSH-13 culture broth led to a significant increase in the glucose consumption rate (26.3%) and pyruvate production (22.5%), but the ratio of NADH/NAD+ decreased to 0.22. Acetaldehyde did not affect the glucose and energy metabolism at high dissolved oxygen (DO) concentration. However, at lower DO concentration (20%), maintaining the acetaldehyde concentration in the mutant culture broth at 4 mg l(-1) caused an increased NAD+ concentration but a decreased NADH concentration. As a consequence, the pyruvate production rate, the pyruvate yield on glucose and the pyruvate concentration were 68, 44 and 45% higher, respectively, than the corresponding values of the control (without acetaldehyde). The strategy for increasing the glycolytic flux and the pyruvate productivity in T. glabrata by increasing the availability of NAD+ may provide an alternative approach to enhance the metabolites productivity in yeast.


Asunto(s)
Candida glabrata/metabolismo , Técnicas de Cultivo de Célula/métodos , Mejoramiento Genético/métodos , NAD/metabolismo , Ácido Pirúvico/metabolismo , Disponibilidad Biológica , Candida glabrata/genética
12.
Clin Infect Dis ; 39(5): 743-6, 2004 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-15356792

RESUMEN

Infection with voriconazole-resistant fungi may become problematic, because organisms with decreased susceptibility have been noted. Breakthrough fungal infections occurred in 13 of 139 patients who received voriconazole at our center during the period of September 1998 through September 2003. Zygomycetes were found in 6 patients, and Candida glabrata bloodstream infection occurred in 4 patients. Minimal inhibitory concentrations were > or =1 microg/mL for all available isolates. Yeasts and molds with decreased susceptibility to voriconazole may cause invasive infection in patients treated successfully for aspergillosis.


Asunto(s)
Farmacorresistencia Fúngica/efectos de los fármacos , Pirimidinas/uso terapéutico , Trasplante de Células Madre/efectos adversos , Triazoles/uso terapéutico , Adulto , Aspergilosis/tratamiento farmacológico , Aspergillus/efectos de los fármacos , Aspergillus/aislamiento & purificación , Candida glabrata/efectos de los fármacos , Candida glabrata/metabolismo , Candida glabrata/fisiología , Candidiasis/tratamiento farmacológico , Candidiasis/metabolismo , Niño , Farmacorresistencia Fúngica/fisiología , Femenino , Fungemia/tratamiento farmacológico , Fungemia/metabolismo , Hongos/efectos de los fármacos , Hongos/aislamiento & purificación , Hongos/fisiología , Humanos , Huésped Inmunocomprometido/fisiología , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Estudios Retrospectivos , Voriconazol , Cigomicosis/tratamiento farmacológico , Cigomicosis/metabolismo
13.
Sheng Wu Gong Cheng Xue Bao ; 20(1): 115-9, 2004 Jan.
Artículo en Chino | MEDLINE | ID: mdl-16108501

RESUMEN

The capability of utilizing the intermediates of TCA-cycle as the sole carbon source by the multi-vitamin auxotrophic yeast Torulopsis glabrata CCTCC M202019 under the conditions of vitamins limitation was demonstrated. Furthermore, the colony numbers grown on medium supplemented with glucose, acetate and one of the intermediates of TCA-cycle was higher than that of medium used glucose and acetate or medium used one of the intermediates of TCA-cycle carbon source. Among the intermediates of TCA-cycle used in this study, oxaloacetate was the best carbon source for the yeast and it was found that its presence stimulated the conversion of acetate to acetyl-CoA. In batch fermentation with glucose medium, the addition of 10 g/L of oxaloacetate improved the dry cell weight from 11.8 g/L to 13.6 g/L, and the productivity of pyruvate from 0.96 g x L(-1) x h(-1) to 1.19 g x L(-1) x h(-1), a 24% increase after 56 h growth. The yield of pyruvate on glucose was also improved as well, from 0.63 g/g to 0.66 g/g.


Asunto(s)
Candida glabrata/metabolismo , Ciclo del Ácido Cítrico , Ácido Pirúvico/metabolismo , Candida glabrata/crecimiento & desarrollo , Medios de Cultivo , Fermentación
14.
Antimicrob Agents Chemother ; 47(3): 847-53, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12604511

RESUMEN

Over the past two decades, the incidence of infections due to Candida glabrata, a yeast with intrinsic low susceptibility to azole antifungals, has increased markedly. Respiratory deficiency due to mutations in mitochondrial DNA (mtDNA) associated with resistance to azoles frequently occurs in vitro in this species. In order to specify the relationships between respiration and azole susceptibility, the effects of respiratory chain inhibitors on a wild-type isolate of C. glabrata were evaluated. Respiration of blastoconidia was immediately blocked after extemporaneous addition of potassium cyanide, whereas a 4-h preincubation was required for sodium azide. Antifungal susceptibility determined by a disk diffusion method on Casitone agar containing sodium azide showed a significant decrease in the susceptibility to azoles. Biweekly subculturing on Casitone agar supplemented with sodium azide was therefore performed. This resulted after 40 passages in the isolation of a respiration-deficient mutant, as suggested by its lack of growth on glycerol-containing agar. This respiratory deficiency was confirmed by flow cytometric analysis of blastoconidia stained with rhodamine 123 and by oxygraphy. Moreover, transmission electron microscopy and restriction endonuclease analysis of the mtDNA of mutant cells demonstrated the mitochondrial origin of the respiratory deficiency. Finally, this mutant exhibited cross-resistance to all the azoles tested. In conclusion, blockage of respiration in C. glabrata induces decreased susceptibility to azoles, culminating in azole resistance due to the deletion of mtDNA. This mechanism could explain the induction of petite mutations by azole antifungals which have been demonstrated to act directly on the mitochondrial respiratory chain.


Asunto(s)
Antifúngicos/farmacología , Azoles/farmacología , Candida glabrata/efectos de los fármacos , Candida glabrata/metabolismo , Consumo de Oxígeno/efectos de los fármacos , Consumo de Oxígeno/genética , Antimetabolitos/farmacología , Candida glabrata/genética , Medios de Cultivo , ADN Mitocondrial/genética , Transporte de Electrón/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Etidio/farmacología , Citometría de Flujo , Pruebas de Sensibilidad Microbiana , Microscopía Electrónica , Mutación , Azida Sódica/farmacología
15.
Sheng Wu Gong Cheng Xue Bao ; 19(6): 745-9, 2003 Nov.
Artículo en Chino | MEDLINE | ID: mdl-15971591

RESUMEN

A large amount of alpha-ketoglutarate (alpha-KG) (6.8 g/L) was accumulated in flask culture when CaCO3 was used as a buffering agent in the production of pyruvate by multi-vitamin auxotrophic yeast Torulopsis glabrata CCTCC M202019. In a 5 L jar-fermentor, less alpha-KG (1.3 g/L) was produced when NaOH was used to adjust the pH, while more alpha-KG (11.5 g/L) detected when CaCO3 was used as the buffer. In the latter case, the molar carbon ratio of pyruvate to alpha-KG (C(PYR)/ CalphaKG) was similar to that obtained in flask culture, suggesting the accumulation of alpha-ketoglutarate was related to the addition of CaCO3. Furthermore, it was found that: (1) delaying the addition time of CaCO3 decreased the a-ketoglutarate formation but increased C(PYR)/ C(alphaKG); and (2) under vitamin limitation conditions increasing the concentration of CaCO3 led to an increased a-KG accumulation at the expenses of pyruvate. To study which ions in CaCO3 was responsible for the accumulation of alpha-KG, the effects of different pH buffers on the a-KG accumulation were studied. The level of alpha-KG was found to correlate with the levels of both Ca2+ and CO3(2-), with Ca2+ played a dominant role and CO3(2-) played a minor role. To find out which pathway was responsible for the accumulation of alpha-KG, the effects of biotin and thiamine on alpha-KG accumulation was investigated. The increase in biotin concentration led to an increase in alpha-KG accumulation and a decrease in C(PYR)/ C(alpha-KG), while the levels of alpha-KG and C(PYR)/C(alphaKG) were not affected by thiamine concentration. The activity of pyruvate carboxylase was increased as much as 40% when the medium was supplemented with Ca2+ . On the other hand, the activity of the pyruvate dehydrogenase complex was unaffected by the presence of Ca2+. To conclude, the higher level of a-KG was caused by higher activity of pyruvate carboxylase stimulated by Ca2+, with CO3(2-) served as the substrate of the reaction.


Asunto(s)
Carbonato de Calcio/farmacología , Candida glabrata/efectos de los fármacos , Candida glabrata/metabolismo , Fermentación/efectos de los fármacos , Ácidos Cetoglutáricos/metabolismo , Ácido Pirúvico/metabolismo , Biotecnología/métodos , Modelos Biológicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA